Scientist I/II, In Vivo Pharmacology
Lexeo Therapeutics Inc - New York, New York
Posted Oct 21, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- Not verified
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Role
- Seniority
- Mid From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Scientist I/II, In Vivo Pharmacology New York, New York Role Summary Lexeo is seeking a hands-on in vivo pharmacologist to build rodent models of cardiac disease and use them to de-risk targets, screen therapeutic candidates and advance our discovery pipeline. The scientist will design, perform or manage rodent studies from target validation through hit identification, working cross-functionally with In Vitro Pharmacology, Modality Engineering, and Translational Sciences to select-advance molecules. Reporting to the Head of Cardiac Research, this role joins cardiac, neuroscience, and non-clinical scientists developing therapies for genetic heart disease and offers broad experience in multidisciplinary biopharma research. Role Summary Lexeo is seeking a hands-on in vivo pharmacologist to build rodent models of cardiac disease and use them to de-risk targets, screen therapeutic candidates and advance our discovery pipeline. The scientist will design, perform or manage rodent studies from target validation through hit identification, working cross-functionally with In Vitro Pharmacology, Modality Engineering, and Translational Sciences to select-advance molecules. Reporting to the Head of Cardiac Research, this role joins cardiac, neuroscience, and non-clinical scientists developing therapies for genetic heart disease and offers broad experience in multidisciplinary biopharma research. Primary Responsibilities - Design and execute in vivo studies that de-risk novel targets, using genetic knockdown/overexpression and tool molecules to test target-phenotype links - Outsource or internally establish rodent cardiac disease models, including transgenic lines and surgical models such as TAC and MI - Run therapeutic screening studies that rank candidates on efficacy, dose-response, durability, and identify hit molecules for advancement - Dose
Read the full description at jobs.lever.co. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Scientist I/II, Modality Engineering
Lexeo Therapeutics Inc - New York, New York
Inflammation Research - In Vivo Pharmacology Scientist
Amgen - US - California - South San Francisco
Associate Scientist I/II, In Vivo Pharmacology
AbbVie Inc. - North Chicago, IL, United States
Scientist, In Vivo Pharmacology
Serif Health - Cambridge, MA